Pathalys Pharma
Clinical trials sponsored by Pathalys Pharma, explained in plain language.
-
New drug aims to tame parathyroid glands in dialysis patients
Disease control CompletedThis study tested a drug called PLS240 in 412 adults with end-stage kidney disease on dialysis who also have overactive parathyroid glands (secondary hyperparathyroidism). Participants received either PLS240 or a placebo intravenously three times a week for 27 weeks, followed by …
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated Jun 26, 2026 14:53 UTC
-
New drug aims to tame parathyroid glands in dialysis patients
Disease control CompletedThis study tested a drug called PLS240 in 362 adults with end-stage kidney disease on dialysis who also have overactive parathyroid glands (secondary hyperparathyroidism). Participants received either PLS240 or a placebo during dialysis three times a week for 27 weeks, followed b…
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated Jun 26, 2026 14:38 UTC